½ÃÀ庸°í¼­
»óǰÄÚµå
1799472

¼¼°èÀÇ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ ½ÃÀå : ½ÃÀå ±Ô¸ð ºÐ¼® - À¯Çüº°, Àü»ç ¹æ¹ýº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°°ú ¿¹Ãø(2022-2032³â)

Global Transfer Membrane Market Size study & Forecast, by Type, Transfer Method, Application, End User and Regional Forecasts 2022-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 285 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ ½ÃÀåÀº 2024³â¿¡ ¾à 4¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2025-2035³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 4.12%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

»ý¸í°úÇÐ ¿¬±¸ ¹× Áø´Ü °Ë»ç¿¡ ÇʼöÀûÀÎ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ(Àü»ç¸·)Àº ´Ü¹éÁú, ÇÙ»ê ¹× ±âŸ »ýüºÐÀÚ¸¦ °íÁ¤È­ÇÏ°í °ËÃâÇÏ´Â Áß¿äÇÑ ±âÁú ¿ªÇÒÀ» ÇÕ´Ï´Ù. µ¶Æ¯ÇÑ Ç¥¸é È­ÇÐÀ» ÅëÇØ ¿¬±¸ÀÚµéÀº º¹ÀâÇÑ »ý¹°ÇÐÀû »ùÇÃÀ» ³ôÀº ƯÀ̼º°ú °¨µµ·Î ÇÁ·ÎºêÇÒ ¼ö ÀÖ¾î ¿þ½ºÅÏ ºí·ÎÆÃ, ¼­´ø ºí¶ùÆÃ, ³ë´ø ºí¶ùÆÃ, ´Ü¹éÁú ½ÃÄö½Ì ¹× °í±Þ ¾Æ¹Ì³ë»ê ºÐ¼®¿¡ ÇʼöÀûÀÔ´Ï´Ù. ½ÃÀå È®´ë´Â ´Ü¹éÁúüÇÐ ¹× À¯ÀüüÇÐ ¿¬±¸ÀÇ ±ÞÁõ, Áúº´ÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ¼¼°èÀÇ °ü½É Áõ°¡, ÀÓ»ó ¹× Çмú ½ÇÇè½Ç¿¡¼­ ³ôÀº 󸮷® ½ºÅ©¸®´× ±â¼úÀÇ ÅëÇÕÀÇ ¹ßÀü¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÚµ¿È­µÈ µðÁöÅÐ ºí·ÎÆÃ ½Ã½ºÅÛÀ¸·ÎÀÇ ÀüȯÀº Â÷¼¼´ë À̹Ì¡ Ç÷§Æû°ú ȣȯµÇ´Â ¸âºê·¹Àο¡ ´ëÇÑ ¼ö¿ä¿¡ ¹ÚÂ÷¸¦ °¡Çϰí Á¦Á¶¾÷ü °£ÀÇ °ß°íÇÑ Çõ½Å ÆÄÀÌÇÁ¶óÀÎÀ» ¼ºÀå½Ã۰í ÀÖ½À´Ï´Ù.

¸¸¼º Áúȯ ¹× °¨¿° Áõ°¡·Î ÀÎÇØ Á¤È®Çϰí ÀçÇö¼ºÀÌ ³ôÀº »ýüºÐÀÚ ºÐ¼®¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, °í±Þ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¸âºê·¹ÀÎÀº ¼¼¹Ì µå¶óÀÌ, µå¶óÀÌ, ÅÊÅ© ÀüÇØÁú ¸âºê·¹Àΰú °°Àº ´Ù¾çÇÑ ÀÌ¼Û ¹æ¹ýÀ¸·Î ¼º´ÉÀ» ¹ßÈÖÇϵµ·Ï ¼³°èµÇ¾úÀ¸¸ç °¢°¢Àº ƯÁ¤ ¿¬±¸ ¿ä±¸ »çÇ×À» ÃæÁ·ÇÕ´Ï´Ù. °áÇÕ´É, ³»¾àǰ¼º, Àú¹è°æ ³ëÀÌÁ °³¼±ÇÑ PVDF³ª ´ÏÆ®·Î¼¿·ê·Î¿À½º¸·ÀÇ ÁøÈ­´Â ¿¬±¸³ª Áø´Ü¿¡ À־ÀÇ ºÐ¼® °á°ú¸¦ ´ëÆø °³¼±Çß½À´Ï´Ù. ¾÷°è µ¥ÀÌÅÍ¿¡ ÀÇÇϸé Á¦¾àȸ»ç, Áø´Üȸ»ç, ¿¬±¸±â°ü °£ Çù·Â°ü°è Áõ°¡·Î Á¦Ç° °³¹ß »çÀÌŬÀÌ °¡¼ÓÈ­µÇ¾î Ư¼öÇÑ ¿ëµµ¿¡ ¸Â´Â ¸· ¼Ö·ç¼ÇÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ¶ÇÇÑ ÇÏÀ̺긮µå ¸âºê·¹ÀÎ Æ÷¸ËÀÇ ¹ßÀüÀ¸·Î ´Ü¹éÁú°ú ÇÙ»êÀÇ ÀÌÁß °ËÃâÀÌ °¡´ÉÇØÁ® ±âÁ¸ ±â¾÷ ¹× ½ÅÈï Çõ½ÅÀÚ ¸ðµÎ¿¡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ÀÚ¿øÀÌ ºÎÁ·ÇÑ ½ÇÇè½Ç¿¡¼­ÀÇ ºñ¿ë °¨°¢°ú ´ëü °ËÃâ ±â¼ú°úÀÇ °æÀïÀº ƯÁ¤ ºÐ¾ß¿¡¼­ÀÇ ¼ºÀåÀ» ¾ïÁ¦ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â °íµµ·Î ¹ß´ÞÇÑ »ý¹°ÀÇÇÐ ¿¬±¸ »ýŰè, Á¤ºÎ¿Í ¹Î°£ ¸ðµÎ·ÎºÎÅÍÀÇ ´Ù¾×ÀÇ ÀÚ±Ý ¿øÁ¶, ¼¼°èÀÇ ¸· Á¦Á¶¾÷üÀÇ °­ÇÑ Á¸Àç°¨ µîÀÇ ÇýÅÃÀ» ¹Þ¾Æ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ ½ÃÀå¿¡¼­ ÇöÀç ¾ÐµµÀûÀÎ ÁöÀ§¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¹Ì±¹Àº ±â¼úÀû Çõ½Å°ú ´ë±Ô¸ð ¿¬±¸ ÇÁ·Î±×·¥ÀÇ °ÅÁ¡À¸·Î Áö¼ÓÀûÀ¸·Î ¼ö¿ä¸¦ ȯ±âÇϰí ÀÖ½À´Ï´Ù. À¯·´Àº Çмú¿¬±¸±â°üÀÇ ±¤¹üÀ§ÇÑ ³×Æ®¿öÅ©, ¼ºÀåÇÏ´Â ¹ÙÀÌ¿ÀŬ·¯½ºÅÍ, ºÐÀÚÁø´ÜÀÇ ÀüÀ¯·´ÀûÀÎ ³ë·Â¿¡ ÈûÀÔ¾î µÚ¸¦ À̾ú½À´Ï´Ù. ÇÑÆí ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¬±¸°³¹ßºñ È®´ë, °¨¿°Áõ À¯Çà Áõ°¡, Áß±¹, Àεµ, ÀϺ» µî ±¹°¡¿¡¼­ ¿þ½ºÅÏ ºí·ÎÆÃ°ú À¯Àüü ÇØ¼® ä¿ë È®´ë°¡ ¿øµ¿·ÂÀÌ µÇ¾î 2035³â±îÁö °¡Àå ºü¸£°Ô ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ Áö¿ªÀº ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö Á¦Á¶ÀÇ ÀÚ¸³À» ÃßÁøÇϰí ÀÖÀ¸¸ç, Á¤ºÎÀÇ Áö¿ø Á¤Ã¥¿¡ ÀÇÇØ ½ÃÀå È®´ë¸¦ À§ÇÑ ºñ¿ÁÇÑ Åä¾çÀÌ Çü¼ºµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡µµ »õ·Î¿î ºñÁî´Ï½º ±âȸ°¡ ÀÖÀ¸¸ç, ÀÇ·á ÀÎÇÁ¶ó¿Í Áø´Ü ´É·ÂÀ» °­È­ÇÔÀ¸·Î½á °íǰÁúÀÇ Æ®·£½ºÆÛ ¸âºê·¹Àο¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϱ⠽ÃÀÛÇß½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ¸ñÀûÀº ÃÖ±Ù ¿©·¯ ºÎ¹® ¹× ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ¹àÈ÷°í ÇâÈÄ ¼ö³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â ºÐ¼® ´ë»ó ±¹°¡¿¡¼­ ¾÷°èÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ½ÃÀå Àü¸Á ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃßÁø ¿äÀΰú µµÀü°ú °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¸¶ÀÌÅ©·Î ½ÃÀåÀÇ ÀáÀçÀûÀÎ ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ »ó¼¼ÇÑ ºÎ¹®¿Í ÇÏÀ§ ºÎ¹®Àº ´ÙÀ½°ú °°½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ ½ÃÀå : ºÐ¼® ¹üÀ§ ¹× ¼ö¹ý

  • ºÐ¼® ¸ñÀû
  • ºÐ¼® ¹æ¹ý
    • ¿¹Ãø ¸ðµ¨
    • Ã¥»ó ºÐ¼®
    • ÇÏÇâ½Ä ¹× »óÇâ½Ä Á¢±Ù
  • ºÐ¼® ¼Ó¼º
  • ºÐ¼® ¹üÀ§
    • ½ÃÀå Á¤ÀÇ
    • ½ÃÀå ±¸ºÐ
  • ºÐ¼® ÀüÁ¦Á¶°Ç
    • Æ÷ÇÔ°ú Á¦¿Ü
    • Á¦ÇÑ »çÇ×
    • ºÐ¼® ´ë»ó ±â°£

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • CEO/CXOÀÇ ÀÔÀå
  • Àü·«Àû ÀλçÀÌÆ®
  • ESG ºÐ¼®
  • ÁÖ¿ä ºÐ¼® °á°ú

Á¦3Àå ¼¼°èÀÇ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ ½ÃÀå : ¿ªÇÐ ºÐ¼®

  • ¼¼°èÀÇ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ ½ÃÀåÀ» Á¿ìÇÏ´Â ½ÃÀå ¿ªÇÐ(2024-2035³â)
  • ¼ºÀå ÃËÁø¿äÀÎ
    • ´Ü¹éÁúüÇÐ ¹× À¯ÀüüÇÐ ¿¬±¸ÀÇ ±ÞÁõÀÌ ¼ö¿ä °ßÀÎ
    • ÀÚµ¿È­ ¹× µðÁöÅÐ ºí·ÔÆÃ ½Ã½ºÅÛÀÇ µµÀÔ¿¡ ÀÇÇÑ ½º·çDz Çâ»ó
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °í±Þ ¸âºê·¹ÀÎÀÇ °íºñ¿ë ¹× Ç÷§Æû ȣȯ¼ºÀÇ ¹®Á¦
    • ´ëü °ËÃâ ±â¼ú ¹× ¼Ò¸ðǰ°úÀÇ °æÀï
  • ±âȸ
    • ÇÏÀ̺긮µå ¸âºê·¹ÀÎ Æ÷¸Ë °³¹ß(ÀÌÁß ´Ü¹éÁú ¹× ÇÙ»ê °ËÃâ)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¿¬±¸°³¹ß ¹× Á¦Á¶ È®´ë

Á¦4Àå ¼¼°èÀÇ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ »ê¾÷ ºÐ¼®

  • Porter's Five Forces ºÐ¼®
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • °ø±ÞÀÚÀÇ Çù»ó·Â
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's Five Forces : ¿¹Ãø ¸ðµ¨(2024-2035³â)
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ȯ°æÀû
    • ¹ýÀû
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«(2025³â)
  • ½ÃÀå Á¡À¯À² ºÐ¼®(2024-2025³â)
  • ¼¼°èÀÇ °¡°Ý ºÐ¼® ¹× µ¿Çâ(2025³â)
  • ¾Ö³Î¸®½ºÆ®ÀÇ ±Ç°í ¹× °á·Ð

Á¦5Àå ¼¼°èÀÇ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø : À¯Çüº°(2025-2035³â)

  • ½ÃÀå °³¿ä
  • ¼¼°èÀÇ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ ½ÃÀå ½ÇÀû : ÀáÀç·Â ºÐ¼®(2025³â)
  • ´ÏÆ®·Î¼¿·ê·Î¿À½º Æ®·£½ºÆÛ ¸âºê·¹ÀÎ
  • PVDF Æ®·£½ºÆÛ ¸âºê·¹ÀÎ
  • ³ªÀÏ·Ð Æ®·£½ºÆÛ ¸âºê·¹ÀÎ

Á¦6Àå ¼¼°èÀÇ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø : ¿ëµµº°(2025-2035³â)

  • ½ÃÀå °³¿ä
  • ¼¼°èÀÇ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ ½ÃÀå ½ÇÀû : ÀáÀç·Â ºÐ¼®(2025³â)
  • ¿þ½ºÅÏ ºí·ÎÆÃ
  • ¼­´ø ºí·ÔÆÃ
  • ³ë´ø ºí·ÔÆÃ
  • ´Ü¹éÁú ¼­¿­ ºÐ¼® ¹× ¾Æ¹Ì³ë»ê ºÐ¼®
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ Æ®·£½ºÆÛ ¸âºê·¹ÀÎ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø : Áö¿ªº°(2025-2035³â)

  • Áö¿ª ½ÃÀå ÇöȲ
  • ÁÖ¿ä ¼±Áø±¹ ¹× ½ÅÈï±¹
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • »ç¿ìµð¾Æ¶óºñ¾Æ(KSA)
    • ³²¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï Á¤º¸

  • ÁÖ¿ä ½ÃÀåÀÇ Àü·«
  • Thermo Fisher Scientific Inc.
    • ±â¾÷ °³¿ä
    • ÁÖ¿ä °£ºÎ
    • ±â¾÷ÀÇ ½º³À¼¦
    • À繫 ½ÇÀû(µ¥ÀÌÅÍÀÇ À̿밡´É¼º¿¡ µû¶ó ´Ù¸§)
    • Á¦Ç° ¹× ¼­ºñ½º Æ÷Æ®Æú¸®¿À
    • ÃÖ±Ù °³¹ß
    • ½ÃÀå Àü·«
    • SWOT ºÐ¼®
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare(Cytiva)
  • Pall Corporation
  • Sartorius AG
  • Abcam plc
  • PerkinElmer, Inc.
  • GVS SpA
  • Roche Diagnostics
  • Sigma-Aldrich Corporation
  • Advantec MFS, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Fisher Scientific
  • MilliporeSigma
AJY 25.09.03

The Global Transfer Membrane Market, valued at approximately USD 0.47 billion in 2024, is projected to expand at a compound annual growth rate of 4.12% from 2025 to 2035. Transfer membranes-integral to life sciences research and diagnostic testing-serve as vital substrates for the immobilization and detection of proteins, nucleic acids, and other biomolecules. Their unique surface chemistry enables researchers to probe complex biological samples with high specificity and sensitivity, making them indispensable for western blotting, southern and northern blotting, protein sequencing, and advanced amino acid analysis. Market expansion is being catalyzed by the surge in proteomics and genomics research, the rising global emphasis on early disease detection, and the growing integration of high-throughput screening techniques in both clinical and academic laboratories. Furthermore, the transition toward automated and digital blotting systems is spurring demand for membranes compatible with next-generation imaging platforms, fostering a robust innovation pipeline among manufacturers.

The rising prevalence of chronic and infectious diseases has intensified the need for precise and reproducible biomolecular analysis, thereby driving the demand for advanced transfer membrane technologies. These membranes are engineered to perform under diverse transfer methods, such as semi-dry, dry, and tank electrotransfer, each catering to specific research requirements. The evolution of PVDF and nitrocellulose membranes with improved binding capacity, chemical resistance, and low background noise has significantly improved analytical outcomes in research and diagnostics. According to industry data, increasing collaborations between pharmaceutical firms, diagnostic companies, and research institutions have accelerated product development cycles, allowing for tailored membrane solutions that align with specialized applications. Additionally, advancements in hybrid membrane formats, enabling dual-protein and nucleic acid detection, present lucrative opportunities for both established players and emerging innovators. However, cost sensitivities in resource-limited laboratories and competition from alternative detection technologies could temper growth in certain segments.

North America currently commands a dominant position in the transfer membrane market, benefiting from a highly developed biomedical research ecosystem, substantial funding from both governmental and private sectors, and the strong presence of global membrane manufacturers. The U.S., in particular, remains a hub for technological breakthroughs and large-scale research programs that continually fuel demand. Europe follows closely, supported by its expansive network of academic research institutes, growing biotech clusters, and pan-European initiatives in molecular diagnostics. Meanwhile, the Asia Pacific region is poised for the fastest growth through 2035, driven by expanding R&D expenditure, rising prevalence of infectious diseases, and increasing adoption of western blotting and genomic analysis in countries such as China, India, and Japan. The region's push toward self-reliance in biotech manufacturing and supportive government policies is expected to create a fertile ground for market expansion. Emerging opportunities are also evident in Latin America and the Middle East & Africa, where the strengthening of healthcare infrastructure and diagnostic capabilities is beginning to elevate the demand for high-quality transfer membranes.

Major market player included in this report are:

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare (Cytiva)
  • Pall Corporation
  • Sartorius AG
  • Abcam plc
  • PerkinElmer, Inc.
  • GVS S.p.A.
  • Roche Diagnostics
  • Sigma-Aldrich Corporation
  • Advantec MFS, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Fisher Scientific
  • MilliporeSigma

Global Transfer Membrane Market Report Scope:

  • Historical Data - 2023, 2024
  • Base Year for Estimation - 2024
  • Forecast period - 2025-2035
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Type:

  • Nitrocellulose Transfer Membranes
  • PVDF Transfer Membranes
  • Nylon Transfer Membranes

By Transfer Method:

  • Semi-Dry Electrotransfer
  • Dry Electrotransfer
  • Tank Electrotransfer
  • Others

By Application:

  • Western Blotting
  • Southern Blotting
  • Northern Blotting
  • Protein Sequencing and Amino Acid Analysis
  • Others

By End User:

  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe (ROE)
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2025 to 2035.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Transfer Membrane Market Report Scope & Methodology

  • 1.1. Research Objective
  • 1.2. Research Methodology
    • 1.2.1. Forecast Model
    • 1.2.2. Desk Research
    • 1.2.3. Top Down and Bottom-Up Approach
  • 1.3. Research Attributes
  • 1.4. Scope of the Study
    • 1.4.1. Market Definition
    • 1.4.2. Market Segmentation
  • 1.5. Research Assumption
    • 1.5.1. Inclusion & Exclusion
    • 1.5.2. Limitations
    • 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

  • 2.1. CEO/CXO Standpoint
  • 2.2. Strategic Insights
  • 2.3. ESG Analysis
  • 2.4. Key Findings

Chapter 3. Global Transfer Membrane Market Forces Analysis

  • 3.1. Market Forces Shaping The Global Transfer Membrane Market (2024-2035)
  • 3.2. Drivers
    • 3.2.1. Surge in Proteomics & Genomics Research Driving Demand
    • 3.2.2. Adoption of Automated and Digital Blotting Systems Increasing Throughput
  • 3.3. Restraints
    • 3.3.1. High Cost of Premium Membranes and Platform Compatibility Issues
    • 3.3.2. Competition from Alternative Detection Technologies and Consumables
  • 3.4. Opportunities
    • 3.4.1. Development of Hybrid Membrane Formats (Dual Protein & Nucleic Acid Detection)
    • 3.4.2. Expansion of R&D and Manufacturing in Asia Pacific and Emerging Markets

Chapter 4. Global Transfer Membrane Industry Analysis

  • 4.1. Porter's 5 Forces Model
    • 4.1.1. Bargaining Power of Buyer
    • 4.1.2. Bargaining Power of Supplier
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Forecast Model (2024-2035)
  • 4.3. PESTEL Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top Investment Opportunities
  • 4.5. Top Winning Strategies (2025)
  • 4.6. Market Share Analysis (2024-2025)
  • 4.7. Global Pricing Analysis And Trends 2025
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Transfer Membrane Market Size & Forecasts by Type 2025-2035

  • 5.1. Market Overview
  • 5.2. Global Transfer Membrane Market Performance - Potential Analysis (2025)
  • 5.3. Nitrocellulose Transfer Membranes
    • 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.3.2. Market size analysis, by region, 2025-2035
  • 5.4. PVDF Transfer Membranes
    • 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.4.2. Market size analysis, by region, 2025-2035
  • 5.5. Nylon Transfer Membranes
    • 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.5.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Transfer Membrane Market Size & Forecasts by Application 2025-2035

  • 6.1. Market Overview
  • 6.2. Global Transfer Membrane Market Performance - Potential Analysis (2025)
  • 6.3. Western Blotting
    • 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.3.2. Market size analysis, by region, 2025-2035
  • 6.4. Southern Blotting
    • 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.4.2. Market size analysis, by region, 2025-2035
  • 6.5. Northern Blotting
    • 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.5.2. Market size analysis, by region, 2025-2035
  • 6.6. Protein Sequencing & Amino Acid Analysis
    • 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.6.2. Market size analysis, by region, 2025-2035
  • 6.7. Others
    • 6.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.7.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Transfer Membrane Market Size & Forecasts by Region 2025-2035

  • 7.1. Transfer Membrane Market, Regional Market Snapshot
  • 7.2. Top Leading & Emerging Countries
  • 7.3. North America Transfer Membrane Market
    • 7.3.1. U.S. Transfer Membrane Market
      • 7.3.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.3.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.3.2. Canada Transfer Membrane Market
      • 7.3.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.3.2.2. Application breakdown size & forecasts, 2025-2035
  • 7.4. Europe Transfer Membrane Market
    • 7.4.1. UK Transfer Membrane Market
      • 7.4.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.2. Germany Transfer Membrane Market
      • 7.4.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.2.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.3. France Transfer Membrane Market
      • 7.4.3.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.3.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.4. Spain Transfer Membrane Market
      • 7.4.4.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.4.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.5. Italy Transfer Membrane Market
      • 7.4.5.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.5.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.6. Rest of Europe Transfer Membrane Market
      • 7.4.6.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.6.2. Application breakdown size & forecasts, 2025-2035
  • 7.5. Asia Pacific Transfer Membrane Market
    • 7.5.1. China Transfer Membrane Market
      • 7.5.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.2. India Transfer Membrane Market
      • 7.5.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.2.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.3. Japan Transfer Membrane Market
      • 7.5.3.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.3.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.4. Australia Transfer Membrane Market
      • 7.5.4.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.4.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.5. South Korea Transfer Membrane Market
      • 7.5.5.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.5.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.6. Rest of APAC Transfer Membrane Market
      • 7.5.6.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.6.2. Application breakdown size & forecasts, 2025-2035
  • 7.6. Latin America Transfer Membrane Market
    • 7.6.1. Brazil Transfer Membrane Market
      • 7.6.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.6.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.6.2. Mexico Transfer Membrane Market
      • 7.6.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.6.2.2. Application breakdown size & forecasts, 2025-2035
  • 7.7. Middle East and Africa Transfer Membrane Market
    • 7.7.1. UAE Transfer Membrane Market
      • 7.7.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.7.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.7.2. Saudi Arabia (KSA) Transfer Membrane Market
      • 7.7.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.7.2.2. Application breakdown size & forecasts, 2025-2035
    • 7.7.3. South Africa Transfer Membrane Market
      • 7.7.3.1. Type breakdown size & forecasts, 2025-2035
      • 7.7.3.2. Application breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Thermo Fisher Scientific Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Financial Performance (Subject to Data Availability)
    • 8.2.5. Product/Services Port
    • 8.2.6. Recent Development
    • 8.2.7. Market Strategies
    • 8.2.8. SWOT Analysis
  • 8.3. Merck KGaA
  • 8.4. Bio-Rad Laboratories, Inc.
  • 8.5. GE Healthcare (Cytiva)
  • 8.6. Pall Corporation
  • 8.7. Sartorius AG
  • 8.8. Abcam plc
  • 8.9. PerkinElmer, Inc.
  • 8.10. GVS S.p.A.
  • 8.11. Roche Diagnostics
  • 8.12. Sigma-Aldrich Corporation
  • 8.13. Advantec MFS, Inc.
  • 8.14. Santa Cruz Biotechnology, Inc.
  • 8.15. Fisher Scientific
  • 8.16. MilliporeSigma
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦